International Congress on Cancer Metastasis

cancermetastasis.org

 

Tumor Mutational Burden as a Biomarker in the Evolving Oncology Landscape: TMB is Associated w/ Clinical Response to Single Agent Pembrolizumab

327 views
November 28, 2019
0 Comments
Login to view comments. Click here to Login